The company adheres to scientific and technological innovation

Sichuan New Hawk Biotechnology Co., Ltd. has always adhered to the principles of "prospering enterprises through science and technology" and "prospering enterprises through innovation". Scientific and technological innovation leads the high-quality development of API production, pursues high-quality development of enterprises, increases R&D budgets, and supports core technological breakthroughs. Introduce international advanced technologies and make localized improvements to ensure the quality of API products, promote industrial upgrading, and continuously promote new progress and breakthroughs in high-quality development.
Adhere to people-oriented, innovation-oriented, attract high-end technical and management talents, and optimize team structure. Advocate teamwork, clarify common goals, give timely recognition and praise, and enhance team cohesion. Vigorously promote enterprises to make significant progress in high-tech and high-quality development, enhance competitiveness and achieve long-term sustainable development.
At the same time, take scientific and technological innovation as the core strategy and formulate a long-term technology development plan. Market-oriented, adjust the direction of technology research and development according to market demand, and estimate the market as the guide to ensure that technology and market are closely integrated.

Sichuan New Hawk Biotechnology Co., Ltd. has always adhered to the path of "developing the enterprise through science and technology", increased its investment in product development and technological innovation, and used technological innovation as an inexhaustible driving force for the development of the enterprise, continuously promoted industrial upgrading and corporate economic development, and prompted the enterprise to transform into a high-tech enterprise.
Focusing on enterprise technological innovation, establish an internal innovation mechanism, implement talent training and incentive policies, increase R&D budgets, and encourage company employees to put forward innovative ideas. Stimulate creativity and ensure the sustainability of technological innovation. Resources are tilted towards scientific and technological innovation, and human, material and financial resources required for R&D are prioritized.
 In August 2024, Sichuan New Hawk Biotechnology Co., Ltd. won the "High-tech Award" with the project approval from the provincial technology center, marking a new step in the company's upgrading and technological innovation.

NO. 9

Successfully obtained EU certification for API export（WC）

On March 25, 2024, Sichuan New Hawk Biotechnology Co., Ltd. obtained the Certificate of API Export to EU approved and issued by the Sichuan Medical Products Administration.
It became the first company of the same type in the county with the qualification to export products to the EU. The document approved the export of the company's human-use land Dosmin to the EU, and confirmed that as long as the GMP implemented by it meets the Chinese pharmaceutical GMP requirements, it is equivalent to meeting the EU, WHO and ICHQ7 pharmaceutical GMP requirements.
Sichuan New Hawk Biotechnology Co., Ltd. has always insisted on promoting high-quality development of the company through scientific and technological innovation, and leading the upgrading and progress of raw material drug production through technological progress. It has successfully opened the door to the EU market and resonated with the international market. This marks a solid step forward for the company in scientific and technological innovation and transformation of scientific and technological achievements, and is also another milestone on the road to corporate development.